Providers who regularly bill Medicare for drugs of abuse testing can expect to receive a Comparative Billing Report (CBR) in September. CBRs provide data analysis comparing an individual provider’s claim submissions to the national average. A sample of the CBR letter can be viewed on the CBR website. CBRs are considered by Medicare to be educational tools and are not an indication of wrongdoing. However, a CBR which suggests a provider bills well outside the national average may support internal compliance review efforts. If you receive a CBR on drugs of abuse testing or are interested in better understanding the CBR process, register here for an educational session hosted by the CBR contractor on Wednesday October 6 from 3-4pm EDT to review the drugs of abuse testing CBR.